SION: Sionna Pharma Sotuvga nisbatan narx

Sionna Therapeutics, Inc. (SION) kompaniyasining korporativ logotipi

Sionna Therapeutics Inc (SION) genetika patentlarini ishlab chiqish uchun yetakchi bioximiklarni ishga olmoqda. Ushbu grafik GURU.Markets ma'lumotlariga asoslangan daromad bahosini aks ettiradi, bunda joriy qiymat miqdorida belgilangan. Kompaniya kistik fibroz uchun davolash usullarini ishlab chiqmoqda va oqsil funksiyalarini tiklash orqali daromad olishni maqsad qilgan; biroq, tayyor mahsulotlarning yo'qligi va sinov xarajatlari biznesning kengayish imkoniyatlarini cheklamoqda.

SION: Sionna Therapeutics Inc P/S multiplikatori 04.07.2022 - 16.11.2026

Sionna Therapeutics, Inc. (SION) kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahliliyoti:SION Sionna Pharma
Sionna Therapeutics yetakchi tovari

Kistik fibroz uchun CFTR oqsilini tiklashga e'tibor qaratgan biotexnologiya sektori kompaniyasi Sionna Therapeutics Inc (SION) uchun baholash kelajakdagi bozor istiqbollariga asoslanadi. Sotuvlar nisbatini (price-to-sales multiple) tahlil qilish orqali investor terapiyaning salohiyati uchun to'langan premiumni aniqlash va shishirilgan kutuvlar natijasida yuzaga kelishi mumkin bo'lgan chuqur korreksiya xavfini minimallashtirish uchun aktivning joriy bozor narxini haqiqiy sotuvlar hajmi bilan solishtiradi.

Sionna Therapeutics Inc kimlar bilan raqobatlashadi

TEM (Tempus AI, Inc.) - Bozor kapitallashuvining daromadga nisbati|Qiagen Group - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati IONS|RGEN - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Avidity Biosciences RNA|CRSP: P/S multiplikatori|Kapitalizatsiya va daromad nisbati WGS|RARE (Ultragenyx Pharma) - P/S multiplikatori|P/S multiplikatori Beam Therapeutics Inc.|Narxning daromadga nisbati Sarepta Therapeutics Inc (SRPT)|Twist Bioscience - Kapitalizatsiya va daromad nisbati|10x Genomics Inc - Kapitalizatsiyaning daromadga nisbati|NTLA (Intellia Therapeutics, Inc.) - Narxning sotuvga nisbati|Stoke Corp - P/S multiplikatori|BLFS (BioLife) - Kapitalizatsiya va daromad nisbati|wavelifesciences.com (WVE) - Narxning daromadga nisbati|MAZE - Narx/daromad koeffitsiyenti|PRME (Prime Medicine Inc) - P/S multiplikatori|Taysha Gene Therapies, Inc. - Narxning sotuvga nisbati|P/S multiplikatori QURE|MGTX: Narxning sotuvga nisbati|Narxning daromadga nisbati REGENXBIO RGNX|SLDB: Kapitalizatsiya va daromad nisbati|OCGN: Kapitalizatsiyaning daromadga nisbati|PACB - P/S multiplikatori|BNTC (Benitec Corp) - Kapitalizatsiyaning daromadga nisbati|Narx/daromad multiplikatori Design Corp DSGN|Narxning daromadga nisbati Rocket Pharmaceuticals|P/S multiplikatori 4D Molecular Therapeutics, Inc.|Narxning daromadga nisbati Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EDIT (Editas Medicine, Inc.)|P/S multiplikatori Silence Therapeutics Corp SLN|PRQR - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Codexis Inc CDXS|SGMO: P/S multiplikatori|Kapitalizatsiya va daromad nisbati NAUT|Narxning daromadga nisbati metagenomi.co|P/S multiplikatori Precision BioSciences Inc.|P/S multiplikatori GBIO|Boundless Bio, Inc. - Kapitalizatsiya va daromad nisbati|P/S multiplikatori XCUR (Exicure, Inc.)|Narx/daromad koeffitsiyenti Imunon, Inc. (IMNN)|PHIO - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati MBIO (mustangbio.com)|RNAZ: P/S multiplikatori|Kapitalizatsiya va daromad nisbati BNGO|APDN (Applied DNA Corp) - P/S multiplikatori|BLUE: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati ImmunoPrecise (IPA)|OMGA - Sotuvga nisbatan narx|Narxning daromadga nisbati Singular Genomics OMIC|Bozor kapitallashuvining daromadga nisbati RGLS|Syros Pharmaceuticals, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Telesis Bio Inc. TBIO|TRACON Pharmaceuticals, Inc. (TCON) - Narxning daromadga nisbati|Unity Biotechnology, Inc - Bozor kapitallashuvining daromadga nisbati